C4 Therapeutics, Inc.

CCCC

CCCCC4 Therapeutics, Inc. US flag

NASDAQ Global Select

4.34

USD

-0.04

- -

359.47MMarket Cap

Profitability (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-25.76	-25.59	-18.5	-27.34	-32.82	-29.01	-29.63
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	100
EBITDA Margin (%)	-78.06	-158.35	-177.23	-176.13	-411.17	-660.78	-324.19	-285.23
Operating Margin (%)	-84.64	-165.81	-182.1	-179.39	-416.56	-669.84	-329.3	-290.68
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-81.14	-155.72	-201.72	-183.23	-412.19	-632.17	-295.6	-291.74
Profit Margin (%)	-81.14	-159.48	-199.83	-183.23	-412.19	-638.34	-295.96	-292.08
Net Income to Common Margin (%)	-124.49	-199.09	-199.83	-183.23	-412.19	-638.34	-295.96	-292.08
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	34.83	19.89	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	14	14	23	43	87	71	66	60
ST Debt	1	1	1	1	7	5	6	6
LT Debt	14	13	22	42	80	66	60	54
Total Debt/EBITDA	-0.96	-0.41	-0.39	-0.53	-0.68	-0.52	-0.57	-0.59
Net Debt/EBITDA	2.4	2.67	2.92	0.81	0.14	0.92	0.48	0.73
Total Debt/EBIT	-0.88	-0.39	-0.38	-0.52	-0.67	-0.51	-0.56	-0.57
Net Debt/EBIT	2.22	2.55	2.84	0.8	0.14	0.91	0.47	0.71
EBITDA to Interest Expense	- -	- -	-47.87	-37.6	-57.7	-99.89	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	-48.4	-38.19	-60.18	-101.14	- -	- -
EBIT to Interest Expense	- -	- -	-49.19	-38.29	-58.45	-101.26	- -	- -
Interest Expense	- -	- -	1	2	2	1	- -	- -
Common Equity/Total Assets	-56.92	-99.35	-45.94	-52.83	-91.89	-140.36	-181.26	-205.72
Long-Term Debt/Equity (%)	- -	- -	7.79	10.66	27.72	26.72	27.77	20.9
Long-Term Debt/Capital (%)	32.66	177.36	-13.6	-18.48	-25.97	-14.38	-10.56	-7.9
Long-Term Debt/Total Assets (%)	9.38	10.88	5.47	8.2	18.61	17.47	17.16	14.93
Total Debt/Equity (%)	-18.16	-12.28	8.16	11.01	30.13	28.84	30.44	23.38
Total Debt/Capital (%)	34.41	189.48	-14.24	-19.07	-28.23	-15.52	-11.58	-8.84
Total Debt/Total Assets (%)	9.89	11.63	5.73	8.46	20.23	18.85	18.81	16.7
Net Debt to Equity	45.53	80.87	-61.14	-16.77	-6.32	-51.44	-25.7	-29.08
Net Debt/Capital (%)	-628.54	108.71	50.11	21.72	5.4	21.68	8.9	9.9
EBITDA	-15	-34	-59	-81	-128	-137	-115	-103
EBITDA-CapEx	-18	-35	-59	-82	-133	-139	-116	-103
Operating Income (Loss)	-16	-35	-60	-82	-130	-139	-117	-104

Liquidity (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	1.52	2.69	8.48	6.04	6.2	5.93	5.42	7.52
Current Ratio	5.16	2.88	8.69	6.36	6.46	6.34	5.71	7.81
Quick Ratio	5.13	2.83	8.58	6.15	6.23	6.21	5.49	7.6
CFO/Avg Current Liab	- -	1.93	-1.74	-1.83	-2.21	-2.45	-1.48	-2.52
Common Equity/Total Assets	-56.92	-99.35	-45.94	-52.83	-91.89	-140.36	-181.26	-205.72
Long-Term Debt/Equity (%)	- -	- -	7.79	10.66	27.72	26.72	27.77	20.9
Long-Term Debt/Capital (%)	32.66	177.36	-13.6	-18.48	-25.97	-14.38	-10.56	-7.9
Long-Term Debt/Total Assets (%)	9.38	10.88	5.47	8.2	18.61	17.47	17.16	14.93
Total Debt/Equity (%)	-18.16	-12.28	8.16	11.01	30.13	28.84	30.44	23.38
Total Debt/Capital (%)	34.41	189.48	-14.24	-19.07	-28.23	-15.52	-11.58	-8.84
Total Debt/Total Assets (%)	9.89	11.63	5.73	8.46	20.23	18.85	18.81	16.7
CFO/Total Liabilities	-7.51	24.16	-56.35	-74.23	-74.81	-81.97	-48.76	-96.3
CFO/CapEx	-6.31	41.23	-103.46	-68.1	-19.28	-62.55	-361.98	-162.59
Altman's Z-Score	-0.22	-1.56	1.85	7.06	-0.31	-1.11	-1.69	-2.99

Working Capital (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	0.47	7.29	8.98	8.65	3.13	4.78	13.06
Days Sales Outstanding	- -	777.26	50.07	40.66	42.19	116.7	76.42	27.94
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	377	1,483	288	280	250	- -
- Cash & Cash Equivalents	36	91	182	76	30	127	55	75
+ Preferred Equity and Hybrid Capital	111	111	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	14	14	23	43	87	71	66	60
Enterprise Value	89	34	28	1,216	99	98	71	-189
Total Capital	42	7	-161	-225	-309	-457	-568	-679
Total Debt/Capital (%)	34.41	189.48	-14.24	-19.07	-28.23	-15.52	-11.58	-8.84
Total Debt / EV	0.16	0.4	0.82	0.04	0.88	0.73	0.93	-0.32
EV/Sales	4.6	1.6	0.84	26.56	3.19	4.71	1.98	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	0.61	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	0.6	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	377	1,483	288	280	250	- -
Diluted Enterprise Value	89	34	218	1,449	346	225	260	-15
EV per Share	6.03	1.98	2.46	26.41	2.03	1.97	1.02	- -
TTM Sales	19	21	33	46	31	21	36	36
TTM EBITDA	-15	-34	-59	-81	-128	-137	-115	-103
TTM Operating Income	-16	-35	-60	-82	-130	-139	-117	-104
TTM Cash Flow to Firm	-17	56	-66	-85	-104	-105	-65	-99
TTM Free Cash Flow to Firm	-14	57	-65	-84	-98	-104	-65	-98

Multiples (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-5.66	-17.3	-2.87	-2.67	-3.84	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	89	34	28	1,216	99	98	71	-189
Low Price	- -	- -	22.4	27.84	4.84	1.06	3.43	1.09
EV/Sales	4.6	1.6	0.84	26.56	3.19	4.71	1.98	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-4.97	-21.68	-4.92	-1.35	-4.06	- -
Price/Earnings High	- -	- -	-6.48	-28.11	-12.87	-3.53	-7.83	- -
Price/Earnings Low	- -	- -	-3.84	-15.28	-1.85	-0.4	-2.26	- -
Price/Book Value	- -	- -	-2.05	-5.54	-0.73	-0.53	-0.39	- -
Price/Book Value Average	- -	- -	-1.79	-6.79	-1.59	-0.34	-0.67	- -
Price/Book Value High	- -	- -	-2.34	-8.81	-4.17	-0.88	-1.3	- -
Price/Book Value Low	- -	- -	-1.39	-4.79	-0.6	-0.1	-0.38	- -
Price/Tangible Book Value	- -	- -	1.34	3.81	1	1.14	1.16	- -
Price/Tangible Book Value Average	- -	- -	1.17	4.67	2.18	0.73	1.98	- -
Price/Tangible Book Value High	- -	- -	1.53	6.05	5.7	1.9	3.82	- -
Price/Tangible Book Value Low	- -	- -	0.91	3.29	0.82	0.21	1.1	- -
Price/Sales	- -	- -	11.35	32.38	9.27	13.51	7.02	- -
Price/Sales Average	- -	- -	9.93	39.72	20.27	8.61	12.01	- -
Price/Sales High	- -	- -	12.95	51.5	53.05	22.51	23.16	- -
Price/Sales Low	- -	- -	7.67	28	7.61	2.54	6.69	- -
Price/Cash Flow	- -	- -	-5.6	-17.05	-2.72	-2.63	-3.83	- -
Price/Cash Flow Average	- -	- -	-4.9	-20.91	-5.95	-1.67	-6.56	- -
Price/Cash Flow High	- -	- -	-6.39	-27.11	-15.57	-4.37	-12.65	- -
Price/Cash Flow Low	- -	- -	-3.79	-14.74	-2.23	-0.49	-3.65	- -
Price/Free Cash Flow Average	- -	- -	-4.95	-21.23	-6.28	-1.7	-6.57	- -
Price/Free Cash Flow High	- -	- -	-6.45	-27.52	-16.42	-4.44	-12.68	- -
Price/Free Cash Flow Low	- -	- -	-3.82	-14.96	-2.35	-0.5	-3.66	- -
EV/Sales Average	4.6	1.6	5.15	39	22.12	5.93	12.29	- -
EV/Sales High	4.6	1.6	8.16	50.77	54.89	19.83	23.45	- -
EV/Sales Low	4.6	1.6	2.89	27.27	9.45	- -	6.98	- -
EV/EBITDA Average	-5.9	-1.01	-2.91	-22.14	-5.38	-0.9	-3.79	0.14
EV/EBITDA High	-5.9	-1.01	-4.61	-28.83	-13.35	-3	-7.23	0.14
EV/EBITDA Low	-5.9	-1.01	-1.63	-15.48	-2.3	0.02	-2.15	0.14
EV/EBIT Average	-5.44	-0.96	-2.83	-21.74	-5.31	-0.89	-3.73	0.14
EV/EBIT High	-5.44	-0.96	-4.48	-28.3	-13.18	-2.96	-7.12	0.14
EV/EBIT Low	-5.44	-0.96	-1.59	-15.2	-2.27	0.02	-2.12	0.14
Last Price	- -	- -	33.13	32.2	5.9	5.65	3.6	1.91
High Price	- -	- -	37.8	51.21	33.76	9.41	11.88	4.26
Enterprise Value Average	89	34	171	1,786	688	123	437	-15
Enterprise Value High	89	34	271	2,325	1,707	412	834	-15
Enterprise Value Low	89	34	96	1,249	294	-3	248	-15

Profitability (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-25.76	-25.59	-18.5	-27.34	-32.82	-29.01	-29.63
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	100
EBITDA Margin (%)	-78.06	-158.35	-177.23	-176.13	-411.17	-660.78	-324.19	-285.23
Operating Margin (%)	-84.64	-165.81	-182.1	-179.39	-416.56	-669.84	-329.3	-290.68
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-81.14	-155.72	-201.72	-183.23	-412.19	-632.17	-295.6	-291.74
Profit Margin (%)	-81.14	-159.48	-199.83	-183.23	-412.19	-638.34	-295.96	-292.08
Net Income to Common Margin (%)	-124.49	-199.09	-199.83	-183.23	-412.19	-638.34	-295.96	-292.08
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	34.83	19.89	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	14	14	23	43	87	71	66	60
ST Debt	1	1	1	1	7	5	6	6
LT Debt	14	13	22	42	80	66	60	54
Total Debt/EBITDA	-0.96	-0.41	-0.39	-0.53	-0.68	-0.52	-0.57	-0.59
Net Debt/EBITDA	2.4	2.67	2.92	0.81	0.14	0.92	0.48	0.73
Total Debt/EBIT	-0.88	-0.39	-0.38	-0.52	-0.67	-0.51	-0.56	-0.57
Net Debt/EBIT	2.22	2.55	2.84	0.8	0.14	0.91	0.47	0.71
EBITDA to Interest Expense	- -	- -	-47.87	-37.6	-57.7	-99.89	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	-48.4	-38.19	-60.18	-101.14	- -	- -
EBIT to Interest Expense	- -	- -	-49.19	-38.29	-58.45	-101.26	- -	- -
Interest Expense	- -	- -	1	2	2	1	- -	- -
Common Equity/Total Assets	-56.92	-99.35	-45.94	-52.83	-91.89	-140.36	-181.26	-205.72
Long-Term Debt/Equity (%)	- -	- -	7.79	10.66	27.72	26.72	27.77	20.9
Long-Term Debt/Capital (%)	32.66	177.36	-13.6	-18.48	-25.97	-14.38	-10.56	-7.9
Long-Term Debt/Total Assets (%)	9.38	10.88	5.47	8.2	18.61	17.47	17.16	14.93
Total Debt/Equity (%)	-18.16	-12.28	8.16	11.01	30.13	28.84	30.44	23.38
Total Debt/Capital (%)	34.41	189.48	-14.24	-19.07	-28.23	-15.52	-11.58	-8.84
Total Debt/Total Assets (%)	9.89	11.63	5.73	8.46	20.23	18.85	18.81	16.7
Net Debt to Equity	45.53	80.87	-61.14	-16.77	-6.32	-51.44	-25.7	-29.08
Net Debt/Capital (%)	-628.54	108.71	50.11	21.72	5.4	21.68	8.9	9.9
EBITDA	-15	-34	-59	-81	-128	-137	-115	-103
EBITDA-CapEx	-18	-35	-59	-82	-133	-139	-116	-103
Operating Income (Loss)	-16	-35	-60	-82	-130	-139	-117	-104

Liquidity (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	1.52	2.69	8.48	6.04	6.2	5.93	5.42	7.52
Current Ratio	5.16	2.88	8.69	6.36	6.46	6.34	5.71	7.81
Quick Ratio	5.13	2.83	8.58	6.15	6.23	6.21	5.49	7.6
CFO/Avg Current Liab	- -	1.93	-1.74	-1.83	-2.21	-2.45	-1.48	-2.52
Common Equity/Total Assets	-56.92	-99.35	-45.94	-52.83	-91.89	-140.36	-181.26	-205.72
Long-Term Debt/Equity (%)	- -	- -	7.79	10.66	27.72	26.72	27.77	20.9
Long-Term Debt/Capital (%)	32.66	177.36	-13.6	-18.48	-25.97	-14.38	-10.56	-7.9
Long-Term Debt/Total Assets (%)	9.38	10.88	5.47	8.2	18.61	17.47	17.16	14.93
Total Debt/Equity (%)	-18.16	-12.28	8.16	11.01	30.13	28.84	30.44	23.38
Total Debt/Capital (%)	34.41	189.48	-14.24	-19.07	-28.23	-15.52	-11.58	-8.84
Total Debt/Total Assets (%)	9.89	11.63	5.73	8.46	20.23	18.85	18.81	16.7
CFO/Total Liabilities	-7.51	24.16	-56.35	-74.23	-74.81	-81.97	-48.76	-96.3
CFO/CapEx	-6.31	41.23	-103.46	-68.1	-19.28	-62.55	-361.98	-162.59
Altman's Z-Score	-0.22	-1.56	1.85	7.06	-0.31	-1.11	-1.69	-2.99

Working Capital (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	0.47	7.29	8.98	8.65	3.13	4.78	13.06
Days Sales Outstanding	- -	777.26	50.07	40.66	42.19	116.7	76.42	27.94
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	377	1,483	288	280	250	- -
- Cash & Cash Equivalents	36	91	182	76	30	127	55	75
+ Preferred Equity and Hybrid Capital	111	111	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	14	14	23	43	87	71	66	60
Enterprise Value	89	34	28	1,216	99	98	71	-189
Total Capital	42	7	-161	-225	-309	-457	-568	-679
Total Debt/Capital (%)	34.41	189.48	-14.24	-19.07	-28.23	-15.52	-11.58	-8.84
Total Debt / EV	0.16	0.4	0.82	0.04	0.88	0.73	0.93	-0.32
EV/Sales	4.6	1.6	0.84	26.56	3.19	4.71	1.98	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	0.61	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	0.6	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	377	1,483	288	280	250	- -
Diluted Enterprise Value	89	34	218	1,449	346	225	260	-15
EV per Share	6.03	1.98	2.46	26.41	2.03	1.97	1.02	- -
TTM Sales	19	21	33	46	31	21	36	36
TTM EBITDA	-15	-34	-59	-81	-128	-137	-115	-103
TTM Operating Income	-16	-35	-60	-82	-130	-139	-117	-104
TTM Cash Flow to Firm	-17	56	-66	-85	-104	-105	-65	-99
TTM Free Cash Flow to Firm	-14	57	-65	-84	-98	-104	-65	-98

Multiples (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-5.66	-17.3	-2.87	-2.67	-3.84	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	89	34	28	1,216	99	98	71	-189
Low Price	- -	- -	22.4	27.84	4.84	1.06	3.43	1.09
EV/Sales	4.6	1.6	0.84	26.56	3.19	4.71	1.98	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-4.97	-21.68	-4.92	-1.35	-4.06	- -
Price/Earnings High	- -	- -	-6.48	-28.11	-12.87	-3.53	-7.83	- -
Price/Earnings Low	- -	- -	-3.84	-15.28	-1.85	-0.4	-2.26	- -
Price/Book Value	- -	- -	-2.05	-5.54	-0.73	-0.53	-0.39	- -
Price/Book Value Average	- -	- -	-1.79	-6.79	-1.59	-0.34	-0.67	- -
Price/Book Value High	- -	- -	-2.34	-8.81	-4.17	-0.88	-1.3	- -
Price/Book Value Low	- -	- -	-1.39	-4.79	-0.6	-0.1	-0.38	- -
Price/Tangible Book Value	- -	- -	1.34	3.81	1	1.14	1.16	- -
Price/Tangible Book Value Average	- -	- -	1.17	4.67	2.18	0.73	1.98	- -
Price/Tangible Book Value High	- -	- -	1.53	6.05	5.7	1.9	3.82	- -
Price/Tangible Book Value Low	- -	- -	0.91	3.29	0.82	0.21	1.1	- -
Price/Sales	- -	- -	11.35	32.38	9.27	13.51	7.02	- -
Price/Sales Average	- -	- -	9.93	39.72	20.27	8.61	12.01	- -
Price/Sales High	- -	- -	12.95	51.5	53.05	22.51	23.16	- -
Price/Sales Low	- -	- -	7.67	28	7.61	2.54	6.69	- -
Price/Cash Flow	- -	- -	-5.6	-17.05	-2.72	-2.63	-3.83	- -
Price/Cash Flow Average	- -	- -	-4.9	-20.91	-5.95	-1.67	-6.56	- -
Price/Cash Flow High	- -	- -	-6.39	-27.11	-15.57	-4.37	-12.65	- -
Price/Cash Flow Low	- -	- -	-3.79	-14.74	-2.23	-0.49	-3.65	- -
Price/Free Cash Flow Average	- -	- -	-4.95	-21.23	-6.28	-1.7	-6.57	- -
Price/Free Cash Flow High	- -	- -	-6.45	-27.52	-16.42	-4.44	-12.68	- -
Price/Free Cash Flow Low	- -	- -	-3.82	-14.96	-2.35	-0.5	-3.66	- -
EV/Sales Average	4.6	1.6	5.15	39	22.12	5.93	12.29	- -
EV/Sales High	4.6	1.6	8.16	50.77	54.89	19.83	23.45	- -
EV/Sales Low	4.6	1.6	2.89	27.27	9.45	- -	6.98	- -
EV/EBITDA Average	-5.9	-1.01	-2.91	-22.14	-5.38	-0.9	-3.79	0.14
EV/EBITDA High	-5.9	-1.01	-4.61	-28.83	-13.35	-3	-7.23	0.14
EV/EBITDA Low	-5.9	-1.01	-1.63	-15.48	-2.3	0.02	-2.15	0.14
EV/EBIT Average	-5.44	-0.96	-2.83	-21.74	-5.31	-0.89	-3.73	0.14
EV/EBIT High	-5.44	-0.96	-4.48	-28.3	-13.18	-2.96	-7.12	0.14
EV/EBIT Low	-5.44	-0.96	-1.59	-15.2	-2.27	0.02	-2.12	0.14
Last Price	- -	- -	33.13	32.2	5.9	5.65	3.6	1.91
High Price	- -	- -	37.8	51.21	33.76	9.41	11.88	4.26
Enterprise Value Average	89	34	171	1,786	688	123	437	-15
Enterprise Value High	89	34	271	2,325	1,707	412	834	-15
Enterprise Value Low	89	34	96	1,249	294	-3	248	-15

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	41	41	43	49	49	60	71	97
Diluted Weighted Avg Shares	15	17	11	46	49	50	69	- -
Basic Weighted Avg Shares	15	17	11	46	49	50	69	- -
Revenue per Share	1.31	1.24	2.92	0.99	0.64	0.42	0.51	- -
EBITDA per Share	-1.02	-1.96	-5.17	-1.75	-2.62	-2.76	-1.66	- -
Operating Income per Share	-1.11	-2.06	-5.32	-1.78	-2.65	-2.8	-1.69	- -
Basic EPS, GAAP	-1.63	-2.47	-5.83	-1.82	-2.62	-2.67	-1.52	- -
Basic EPS from Cont Ops	-1.06	-1.98	-5.83	-1.82	-2.62	-2.67	-1.52	- -
Diluted EPS, GAAP	-1.63	-2.47	-5.83	-1.82	-2.62	-2.67	-1.52	- -
Diluted EPS from Cont Ops	-1.06	-1.98	-5.83	-1.82	-2.62	-2.67	-1.52	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.15	3.23	-5.91	-1.89	-2.17	-2.15	-0.94	- -
Free Cash Flow per Basic Share	-1.33	3.15	-5.97	-1.92	-2.28	-2.19	-0.94	- -
Cash & Equivalents per Share	2.46	5.25	32.69	6.72	5.65	5.11	3.53	- -
Book Value per Share	-5.64	-6.82	-16.17	-5.81	-8.1	-10.64	-9.13	- -
Tangible Book Value per Share	-12.9	-12.94	24.7	8.46	5.92	4.96	3.11	- -

C4 Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)